Primus Aerospace Adopts VELO3D’s Titanium AM System to Unlock the Future of Design for the Aerospace and Defense Industry
16.3.2021 16:15:00 EET | Business Wire | Press release
Primus Aerospace—a leading contract manufacturing partner to aerospace, defense & space OEMs—has joined the VELO3D partner network with the purchase of a Ti6Al4V Sapphire® metal additive manufacturing (AM) system.
This is the first titanium-dedicated metal 3D printer from VELO3D that will be used solely for aerospace & defense applications. Primus has identified VELO3D’s AM system as a solution for many applications they currently produce, including cube satellites, hypersonics and turbine engines. The Colorado-based company is a top-tier supplier for the leading defense primes and the majority of aerospace OEMs, including Lockheed, Boeing, Northrop Grumman, General Dynamics, and Raytheon.
“Primus is proud to be a leader in this manufacturing category,” says Gary Vaillancourt, Vice President of Engineering & Technical Sales. “Our customers require maximum performance of their aerospace-related systems and, together with VELO3D, we can redefine what is possible in manufacturing through advanced AM technology.”
The partnership with VELO3D will enable Primus Aerospace to deliver unique design freedom and highest-quality AM services to their customers. Using the VELO3D manufacturing solution, Primus is looking to unlock powerful design and manufacturing capabilities that will enable the realization of previously unattainable geometries and optimized solutions as well as the exploration of novel aerospace applications.
“Primus Aerospace is an excellent partner for us with their customer focus, commitment to innovation, and adoption of leading-edge technology,” says Benny Buller, founder and CEO of VELO3D. “Our capabilities will help them deliver to engineers and supply chain managers the part designs they want, not the limited part geometries that other commodity-AM suppliers say they can have. The synergies between our two companies will support developers of new products to optimize their designs without compromise or restraint.”
Primus Aerospace expects to take delivery of the titanium Sapphire® System in Q1 2021 and will begin offering titanium printing at their facility located in Golden, Colorado.
Learn more about the VELO3D Contract Manufacturing Partner Network. https://www.velo3d.com/partners/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005206/en/
Contact information
Media Contact for Primus:
Gary Vaillancourt
Vice President Engineering & Technical Sales
gvaillancourt@primusaero.com
Media Contact for VELO3D:
Renette Youssef
Chief Marketing Officer
press@velo3d.com
Twitter: https://twitter.com/VELO3DMetal
Facebook: https://www.facebook.com/Velo3Dinc/
LinkedIn: https://www.linkedin.com/company/velo3d/
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Bolivarian Republic of Venezuela Announces the Initiation of a Comprehensive Public Debt Restructuring Process13.5.2026 23:08:00 EEST | Press release
The Bolivarian Republic of Venezuela announces today its decision to initiate a comprehensive restructuring of its external public debt obligations. CONTEXT & RATIONALE Over the past decade, Venezuela's economy has been severely impacted by external shocks – from the end of the commodity super-cycle to foreign sanctions and COVID-19 – resulting in a sharp economic contraction, a protracted default since 2017, and a ballooning of public sector liabilities. The country nonetheless possesses a strong economic potential, including unique hydrocarbon and mineral endowments. A recovery is underway, and Venezuela is committed to accelerating it through a comprehensive reform agenda in support of growth, fiscal sustainability, monetary stabilization, and enhanced governance. Restoring public debt sustainability is central to this agenda: the current debt overhang constrains external financing, limits public investment capacity, and prevents full re-engagement with the international financial s
Boomi Announces Intent to Acquire Lunar.dev to Deliver Governed Agent Connectivity Across the Enterprise13.5.2026 22:00:00 EEST | Press release
Boomi, the data activation company for AI, today announced it has signed a letter of intent to acquire Lunar.dev, an innovator in AI and MCP gateway. The proposed acquisition is expected to enrich the Boomi Enterprise Platform and Boomi Connect with advanced capabilities to govern and scale AI usage across enterprise systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513850557/en/ Boomi Announces Intent to Acquire Lunar.dev to Deliver Governed Agent Connectivity Across the Enterprise As organizations move from AI experimentation to production, controlling how agents and AI applications interact with LLMs at scale has become critical. Lunar.dev addresses this need with an AI gateway that delivers granular, policy-driven control over AI interactions, with the visibility, security, and performance required for enterprise environments. These capabilities enable organizations to move from pilot to production with confiden
BeOne Medicines’ BEQALZI ™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma13.5.2026 20:27:00 EEST | Press release
BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to BEQALZI™(bee-KAHL-zee; sonrotoclax), a foundational, next-generation BCL2 inhibitor, for the treatment of adult patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL), after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase (BTK) inhibitor. BEQALZI was designed to enhance BCL2 inhibition—with greater potency, selectivity, and a pharmacologic profile with potential to improve efficacy, tolerability, and convenience over others in the class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513542161/en/ BeOne Medicines' flagship U.S. biologics manufacturing and clinical R&D facility at the Princeton West Innovation Campus in Hopewell, N.J. Michael Wang, M.D., Global Principal Investigator
Boomi Unveils Innovations That Power the Agentic Enterprise13.5.2026 17:30:00 EEST | Press release
Boomi, the data activation company for AI, today announced a major expansion of the Boomi Enterprise Platform at Boomi World 2026, introducing new capabilities across orchestrated agentic workflows, agentic engineering, governed agent connectivity, grounded agent context, and localized agent infrastructure. Together, these innovations are designed to power the agentic enterprise — where agents and humans work together to drive action and operationalize AI at scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513996223/en/ Boomi Unveils Innovations That Power the Agentic Enterprise The enterprise has reached a defining moment as AI becomes the primary interface for work and MCP emerges as the new standard. While the shift toward a headless, agentic enterprise is inevitable, this vision is colliding with skyrocketing cloud costs and trapped data. For many, layering agents onto a fragmented landscape only magnifies govern
Boomi and Couchbase Partner to Power Enterprise AI Agents with Trusted Recollection, Connectivity, and Governance13.5.2026 17:30:00 EEST | Press release
Boomi, the data activation company for AI, and Couchbase, Inc., the operational data platform for AI, today announced a partnership through which the two companies are collaborating closely to accelerate AI pilots to production. The companies will co-engineer solutions that give customers a production-ready foundation for agentic AI, combining Boomi's connectivity, runtime, and governance for AI agents with Couchbase's scalable recollection and vector capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513350337/en/ Enterprises deploying AI agents today face a common challenge: while agents perform well in pilots, they struggle to scale due to inconsistent access to trusted context, recollection, and real-time business data. Lack of governance, auditability, and operational control drives up compute costs while diminishing productivity and revenue. “2026 is the year organizations move from AI experimentation to a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom